In this Q&A, Nathan Buchbinder, our Chief Strategy Officer, delves into the impact of DICOM on the pathology industry. He explores the key benefits of this standardization, its implications for AI development, and how it paves the way for a more integrated and innovative future in pathology.
Featured Story:
Latest Articles
March 20, 2025
March 13, 2025